PepGen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

PepGen Stock Summary

PepGen competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, Molecular Partners, and Mineralys Therapeutics,. PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Pepgen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 36 people.

PepGen Key Financial Ratios

PepGen Key Balance Sheet Accounts

PepGen Key Income Statement Accounts

PepGen Key Cash Accounts

PepGen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PepGen's current stock value. Our valuation model uses many indicators to compare PepGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PepGen competition to find correlations between indicators driving PepGen's intrinsic value. More Info.PepGen is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, PepGen's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value PepGen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PepGen Systematic Risk

Today, most investors in PepGen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PepGen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PepGen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of PepGen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PepGen. We use our internally-developed statistical techniques to arrive at the intrinsic value of PepGen based on widely used predictive technical indicators. In general, we focus on analyzing PepGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PepGen's daily price indicators and compare them against related drivers.

When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.